Jpm 2025 Biotech Showcase 2025. News & Events Biocytogen Home / Resources / Conferences / JP Morgan Healthcare Conference and Biotech Showcase 2025 JP Morgan Healthcare Conference and Biotech Showcase 2025 Join us in San Francisco to gather invaluable insights from prominent investors and biopharma executives
JPM Biotech Showcase Presentation — Reglagene Transforming Tubulin Therapy for Brain Diseases from www.reglagene.com
Our experts will be on the ground in San Francisco during the JP Morgan Healthcare Conference, and Biotech Showcase: The Investor Conference for Innovators to discuss your specific asset challenges and how we can drive success across the asset development continuum, providing fit-for-purpose solutions with high-quality delivery. Biotech Showcase™, the investor conference in San Francisco produced by Demy-Colton and EBD Group, is devoted to providing private and public biotechnology and life sciences companies with an opportunity to present to investors and pharmaceutical executives.
The event has been organised by EBD Group & Demy-Colton. 2025 Cell & Gene State of the Industry Briefing: Introduction and Industry Update Biotech Showcase 2025, the investor and partnering conference for private, small- and mid-cap biotech companies, took place 13-15 January 2025 in San Francisco, CA, US
Gene Therapy Archives Commetric. The event has been organised by EBD Group & Demy-Colton. Biotech Showcase 2025, the investor and partnering conference for private, small- and mid-cap biotech companies, took place 13-15 January 2025 in San Francisco, CA, US
Trump’s Project 2025 Platform is the Most Extreme in GOP History What is Project 2025. SAN FRANCISCO--(BUSINESS WIRE)--#BiotechShowcase--Marking its 17th year, Biotech Showcase™ will once again serve as the premier destination for global biopharma leaders to connect and advance innovation during J.P Biotech Showcase™ 2025: 3,200+ Attendees and 1,200+ Investors Set to Convene in San Francisco for Leading Biotech Investor Conference